Investment
Features
FeesSafety
Academy
More
Pluang+

Pomerantz LLP investigates FirstSun Capital Bancorp over suspected securities fraud after loan loss disclosure.

Market News
04 Aug 2026
GlobeNewsWire
View Source
Bearish
pluang ai news

Pomerantz LLP is investigating FirstSun Capital Bancorp and its executives for possible securities fraud following the company's July 9, 2026 announcement of higher-than-expected loan charge-offs and credit loss provisions, including a $22 million charge-off linked to suspected fraud. This news caused FirstSun's stock to drop 7.5% the next day. The investigation aims to determine if unlawful business practices occurred, with investors encouraged to contact Pomerantz for potential class action involvement.

More News

Lyft director Janey Whiteside sells 14,220 shares at $17 each.

Lyft director Janey Whiteside sells 14,220 shares at $17 each.

Lyft director Janey Whiteside sold 14,220 shares of the company's stock at a price of $17 per share. This transaction reflects a significant insider sale, which investors often watch as a signal of confidence or strategic portfolio management. The sa...

Market News
Neutral
2 hours ago
908 Devices beats Q2 revenue estimates with 23% growth and raises 2026 guidance.

908 Devices beats Q2 revenue estimates with 23% growth and raises 2026 guidance.

908 Devices reported strong Q2 results with revenues up 23% year-over-year to $16.07 million, driven by a 35.5% increase in product sales and a 23% growth in its installed base. The company narrowed its operating and net losses while raising its 2026...

Company Fundamentals
Bullish
4 hours ago
Healthcare Triangle's AI segment drives Q2 revenue up 158% to $9.19M, equity jumps to $49.1M.

Healthcare Triangle's AI segment drives Q2 revenue up 158% to $9.19M, equity jumps to $49.1M.

Healthcare Triangle reported a 158% year-over-year revenue increase to $9.19 million in Q2 2026, driven primarily by its AI-powered customer engagement segment, which contributed $6.31 million or 69% of total revenue. Gross profit surged 322% to $2.0...

Company Fundamentals
Bullish
4 hours ago
Pulmatrix files Form S-4 for merger with Eos SENOLYTIX, advancing its biopharma pipeline and licensing strategy.

Pulmatrix files Form S-4 for merger with Eos SENOLYTIX, advancing its biopharma pipeline and licensing strategy.

Pulmatrix, a biopharmaceutical company, filed Form S-4 related to its planned merger with Eos SENOLYTIX, a biotech focused on aging-related therapies. The merger, expected to close in Q3 2026, aims to combine Pulmatrix's inhaled drug technology with ...

Company Fundamentals
Bullish
4 hours ago
Stellar doubles tokenized real-world assets to $3B and hits $11.4B stablecoin transfers in Q2 2026

Stellar doubles tokenized real-world assets to $3B and hits $11.4B stablecoin transfers in Q2 2026

In Q2 2026, Stellar's network doubled its tokenized real-world assets to $3.05 billion, growing four times faster than the market average, driven by Protocol 26 upgrade. Stablecoin transfers reached a record $11.4 billion, with 4.9 million daily tran...

Protocol Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App